Ерлотиниб Крка

Erlotinib Krka is an oral medication used for certain types of cancer treatment. It belongs to the class of tyrosine kinase inhibitors. This product is manufactured by Krka and is available for prescription use.

Erlotinib is primarily used to treat non-small cell lung cancer and pancreatic cancer when certain conditions are met. It works by blocking proteins that signal cancer cells to grow. Patients often ask, 'what is Erlotinib used for' in the context of these specific cancer types. This medication may be prescribed when other treatments are not suitable.

Erlotinib is taken orally and may help slow the progression of cancer by interfering with the growth signals in cancer cells. Common effects include gastrointestinal discomfort or skin reactions. Users may experience mild nausea or fatigue during treatment. It is important to monitor any changes while taking this medication.

Erlotinib should be handled with care, especially by those who are pregnant or breastfeeding. Avoid direct contact with crushed or broken tablets. Keep the medication in a safe place away from children and pets. Inform your healthcare provider about any ongoing medical conditions or other medications you are taking.

Erlotinib may interact with certain medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness. Grapefruit and grapefruit juice may also interact with Erlotinib. Alcohol use should be discussed with a healthcare provider. Always consult a professional before combining this medication with other substances.